Bufalin: a potential drug for regulating EGFR-TKIs resistance in lung cancer via the EGFR-PI3K/Akt-mTOR signaling
tcr.amegroups.org/article/view/109924/html
tcr.amegroups.orgPosted Feb 19, 2026, 3:16 PM UTC
10
tcr.amegroups.orgLoading comments…
tcr.amegroups.org